首页|血清α1-抗胰蛋白酶和颗粒蛋白前体对慢性阻塞性肺疾病急性加重期的诊断价值

血清α1-抗胰蛋白酶和颗粒蛋白前体对慢性阻塞性肺疾病急性加重期的诊断价值

扫码查看
目的 探讨血清α1-抗胰蛋白酶和颗粒蛋白前体对慢性阻塞性肺疾病急性加重期的诊断价值.方法 选取驻马店市中心医院和河南省胸科医院2020年6月至2023年6月收治的慢性阻塞性肺疾病急性加重期103例患者作为观察组,选取同期就诊的103例稳定期慢性阻塞性肺病患者作为对照组.两组患者清晨抽取静脉血,测定对照组和观察组患者血清α1-抗胰蛋白酶和颗粒蛋白前体水平变化.将急性加重期慢性阻塞性肺疾病患者根据简化急性生理学评分Ⅱ分为轻度、中度和重度,比较血清α1-抗胰蛋白酶和颗粒蛋白前体水平变化;根据患者是否发生呼吸衰竭,将患者分为呼吸衰竭组和无呼吸衰竭组,比较血清α1-抗胰蛋白酶和颗粒蛋白前体水平变化.并采用受试者工作曲线分析血清α1-抗胰蛋白酶和颗粒蛋白前体水平与患者呼吸衰竭的关系.组间计量数据采用独立样本t 检验.结果 对照组患者血清α1-抗胰蛋白酶和颗粒蛋白前体水平[(6.18±1.52)mg/L、(159.90±41.57)µg/L]明显低于观察组患者[(9.86±2.85)mg/L、(200.20±46.26)μg/L],差异有统计学意义(t=11.550,6.251,P<0.05).轻度慢性阻塞性肺疾病急性加重期患者血清α1-抗胰蛋白酶和颗粒蛋白前体水平[(6.98±0.82)mg/L、(148.51±16.70)μg/L]明显低于中度患者[(9.43±0.78)mg/L、(201.54±19.75)µg/L],差异有统计学意义(t=12.360,11.820,P<0.05).中度慢性阻塞性肺疾病急性加重期患者血清α1-抗胰蛋白酶和颗粒蛋白前体水平[(9.43±0.78)mg/L、(201.54±19.75)μg/L]明显低于重度患者[(13.01±1.80)mg/L、(249.42±17.76)μg/L],差异有统计学意义(t=10.150,10.440,P<0.05).无呼吸衰竭慢性阻塞性肺疾病急性加重期患者血清α1-抗胰蛋白酶和颗粒蛋白前体水平[(7.98±1.50)mg/L、(167.68±30.17)μg/L]明显低于呼吸衰竭患者[(12.37±2.23)mg/L、(243.81±21.27)μg/L],差异有统计学意义(t=14.290,11.920,P<0.05).血清α1-抗胰蛋白酶水平预测呼吸衰竭的曲线下面积分别为 0.891(95%:0.847,0.974),敏感度为 82.1%(95%:0.785,0.974),特异性为 78.9%(95%:0.722,0.894);血清颗粒蛋白前体水平预测呼吸衰竭的曲线下面积分别为0.859(95%:0.801,0.946),敏感度为 78.9%(95%:0.729,0.889),特异性为 85.6%(95%:0.804,0.924).血清α1-抗胰蛋白酶和颗粒蛋白前体联合诊断呼吸衰竭的曲线下面积分别为0.915(95%:0.865,0.971),敏感度为 89.8%(95%:0.822,0.938),特异性为 94.7%(95%:0.877,0.976).结论 血清α1-抗胰蛋白酶和颗粒蛋白前体在慢性阻塞性肺疾病急性加重期显著升高,是疾病加重的危险因素,可作为慢性阻塞性肺疾病急性加重期诊断的标志物.
Diagnostic value of serum α 1-antitrypsin and progranulin in acute exacerbation of chronic obstructive pulmonary disease
Objective To investigate the diagnostic value of serum α 1-antitrypsin and progranulin in acute exacerbation of chronic obstructive pulmonary disease.Methods 103 patients with acute exacer-bation of chronic obstructive pulmonary disease in Zhumadian central hospital and Henan Provincial chest hospital from June 2020 to June 2023 were selected as the observation group,and 103 patients with stable chronic obstructive pulmonary disease in our hospital were selected as the control group.Venous blood was drawn from the two groups in the morning,and the changes of serum α1-antitrypsin and progranulin levels in the control group and the observation group were measured.The patients with acute exacerbation of chronic obstructive pulmonary disease were divided into mild,moderate and severe according to the Simplified Acute Physiology Score Ⅱ.The changes of serum α1-antitrypsin and progranulin levels were compared;According to whether the patients developed respiratory failure,the patients were divided into respiratory failure group and no respiratory failure group,and the changes of serum α1-antitrypsin and progranulin levels were com-pared.The relationship between serum α1-antitrypsin and progranulin levels and respiratory failure was ana-lyzed by receiver operating curve.Independent sample t-test was used for inter group measurement data.Results The serum levels of α1-antitrypsin and progranulin in the control group[(6.18±1.52)mg/L,(159.90±41.57)μg/L]were significantly lower than those in the observation group[(9.86±2.85)mg/L,(200.20±46.26)μg/L,t=11.550,6.251,P<0.05].The serum levels of α1-antitrypsin and progranu-lin in patients with mild chronic obstructive pulmonary disease at acute exacerbation stage[(6.98±0.82)mg/L,(148.51±16.70)μ g/L]were significantly lower than those in moderate patients[(9.43±0.78)mg/L,(201.54±19.75)μ g/L,t=12.360,11.820,P<0.05].The serum levels of α1-antitryp-sin and progranulin in patients with acute exacerbation of moderate chronic obstructive pulmonary disease[(9.43±0.78)mg/L,(201.54±19.75)µ g/L]were significantly lower than those in severe patients[(13.01±1.80)mg/L,(249.42±17.76)µ g/L,t=10.150,10.440,P<0.05].The serum levels ofα 1-antitrypsin and progranulin in patients with acute exacerbation of chronic obstructive pulmonary disease without respiratory failure[(7.98±1.50)mg/L,(167.68±30.17)µ g/L]were significantly lower than those in patients with respiratory failure[(12.37±2.23)mg/L,(243.81±21.27)μ g/L,t=14.290,11.920,P<0.05].The area under the curve of serum α 1-antitrypsin level in predicting respiratory fail-ure was 0.891(95%:0.847,0.974),the sensitivity was 82.1%(95%:0.785,0.974),and the speci-ficity was 78.9%(95%:0.722,0.894);The area under the curve of serum progranulin level in predic-ting respiratory failure was 0.859(95%:0.801,0.946),the sensitivity was 78.9%(95%:0.729,0.889),and the specificity was 85.6%(95%:0.804,0.924).The area under the curve of combined di-agnosis of serum α1-antitrypsin and progranulin for respiratory failure was 0.915(95%:0.865,0.971),the sensitivity was 89.8%(95%:0.822,0.938),and the specificity was 94.7%(95%:0.877,0.976).Conclusion Serum α 1-antitrypsin and progranulin are significantly increased in the acute exac-erbation of chronic obstructive pulmonary disease,which are risk factors for disease exacerbation,and can be used as markers for the diagnosis of acute exacerbation of chronic obstructive pulmonary disease.

Serum α 1-antitrypsinProgranulinAcute exacerbation of chronic obstructive pulmonary disease

任松涛、赵强、王焕东

展开 >

黄淮学院附属医院(驻马店市中心医院)急诊科,驻马店 463000

河南省胸科医院急诊科,郑州 450008

血清α1-抗胰蛋白酶 颗粒蛋白前体 慢性阻塞性肺疾病急性加重期

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(11)